Abstract An in vitro 3D model was developed utilizing a synthetic microgravity environment to facilitate studying the cell interactions. 2D monolayer cell culture models have been successfully used to understand various cellular reactions that occur in vivo. There are some limitations to the 2D model that are apparent when compared to cells grown in a 3D matrix. For example, some proteins that are not expressed in a 2D model are found up-regulated in the 3D matrix. In this paper, we discuss techniques used to develop the first known large, free-floating 3D tissue model used to establish tumor spheroids. The bioreactor system known as the High Aspect Ratio Vessel (HARVs) was used to provide a microgravity environment. The HARVs promoted aggregation of keratinocytes (HaCaT) that formed a construct that served as scaffolding for the growth of mouse melanoma. Although there is an emphasis on building a 3D model with the proper extracellular matrix and stroma, we were able to develop a model that excluded the use of matrigel. Immunohistochemistry and apoptosis assays provided evidence that this 3D model supports B16.F10 cell growth, proliferation, and synthesis of extracellular matrix. Immunofluorescence showed that melanoma cells interact with one another displaying observable cellular morphological changes. The goal of engineering a 3D tissue model is to collect new information about cancer development and develop new potential treatment regimens that can be translated to in vivo models while reducing the use of laboratory animals.
Introduction
Biologically compatible 3D models produced in artificial microenvironments are typically utilized to study how similar or dissimilar cell types interact, communicate, and signal in the presence of one another (Licato et al. 2001; Smalley et al. 2005; Griffith and Swartz 2006; Fischbach et al. 2007 ). An ideal cell culture model is one where a 3D construct is capable of providing cells the ability to network with one another in an unrestricted manner and independent of other natural stimuli. Furthermore, adding individual mediators one by one to the system can provide information about cellular mechanisms, gene expression, and signaling pathways in isolated biological systems (Licato et al. 2001; Griffith and Swartz 2006; Becker and Blanchard 2007; Fischbach et al. 2007; Yamada and Cukierman 2007) . Investigators interested in 3D models want to analyze specific processes to better understand mechanisms such as receptor up-regulation, protein synthesis, protein phosphorylation, mutation of genes, uncontrollable cancer cell proliferation, and tumor evasion (Hammond and Hammond 2001; Mengus-Feder et al. 2008) . Scientists also want to study what occurs to individual cells when stimulated with metabolites, immune factors, pH, stress, growth factors, hormones, and proliferation signals. A 3D model can serve as a good intermediate between an in vitro and in vivo prototype, reducing the use of laboratory animals for experiments (Hammond and Hammond 2001; Smalley et al. 2005; Yamada and Cukierman 2007; Mengus-Feder et al. 2008 ). An additional advantage of utilizing the in vitro 3D model was the ease of manipulating experimental variables that would provide immediate results compared to an in vivo animal model.
The 3D model in this study consists of growing keratinocytes (HaCaT) into spheroids using bioreactors (Ingram et al. 1997; Synthecon Incorporated 2007) . HaCaT cells mimic epithelia found in mammals, specifically human and mouse, to act as scaffolding that supports cellular growth of tumor cells such as melanoma (Stark et al. 1999; Griffith and Swartz 2006) . In nature and culture, keratinocytes can promote cellular development because they are known to synthesize their own basement membrane (BM) for structural stability similar to the BM sitting on the extracellular matrix (Sudbeck et al. 1997; Rovee and Maibach 2004; Smalley et al. 2005) . In theory, an in vitro 3D model may not need a BM to encourage keratinocyte growth or development. On the other hand, fibronectin is found to be secreted at the cell surface of B16.F10 aggregates when interacting with cell matrix integrins. Fibronectin and integrins are involved in cell attachment and signaling between the inside and outside of the cells (Hindie et al. 2006) . Keratinocytes are known to regulate melanocyte growth and proliferation through expression of adhesion molecules such as cadherins. The aberrant cellcell communication and expression of adhesive properties in neighboring keratinocytes along with mutations in the cell cycle pathways have been predicted to up-regulate the oncogenic properties of melanocytes. In one in vitro study, the overexpression of E-cadherin caused E-cadherinnegative melanoma cells to adhere to keratinocytes, subjecting melanoma to keratinocyte regulation. Keratinocyte regulation allows for continuous growth and survival of melanoma; the regulatory properties of keratinocytes are compromised when fibroblasts and other N-cadherinproducing cells promote metastatic properties and invasion of melanoma cells into subcellular layers (Christofori and Semb 1999; Hsu et al. 2000; Li et al. 2002; Fang and Herlyn 2006) . We hypothesized that the adhesive properties of keratinocytes and production of B16.F10 extracellular matrix in this 3D model would support the structural stability needed to promote B16.F10 cell-cell interaction and tumor proliferation. Normally, B16.F10 cells form a solid tumor, but when the tumor tissue is disrupted, the cells are fluid and do not stick to one another easily (Ghosh and Maity 2007) . Keratinocytes provide the structure to hold B16.F10 cells in proximity to one another and acts as a template for promoting cellular proliferation and differentiation. The studies reported in this paper demonstrate how HaCaT scaffolding aids in promoting B16.F10 tumor development.
Melanoma progression has been studied using other 3D methods, such as the liquid overlay method (Smalley et al. 2006) , matrigel/algi matrix (Gibco, New York, NY), cytodex/plastic beads scaffold (Sigma/Solohill, St. Louis, MO), and Extracel sponges (Glycosan, Salt Lake City, UT). Experimentation using these methods has proven to be successful, promoting cellular aggregates of melanoma ranging in size between 50 and 500 μm in diameter. Although these techniques provide useful information on a microscale, we were interested in obtaining tumor sizes closer to 1 cm in diameter in order to test treatment regimens against melanoma on a macroscale. To our knowledge, this is the first report of generating a large free-floating 3D tumor model of about 1 cm in diameter. Our objectives were to study the characteristics of this in vitro scaffold, how it promotes an environment suitable for tumorgenesis, and how this model can be used to study delivery methods and therapeutic interventions against cancer.
Materials and Methods
Rotating wall vessel bioreactor system. The High Aspect Ratio Vessels (HARVs) promote 3D cell culture growth in a microgravity setting (Synthecon, Houston, TX, Swartz et al. 1992) . The vessels are equipped with two luer lock ports, one sampling port, and six tightening screws. These vessels rotate on their base at 1 gravitational force (G) providing an optimal environment for cells to grow in suspension experiencing minimal shearing and interference by the media or the vessel walls. Cellular expansion occurs in a state of free fall or solid body rotation while floating in media (Swartz et al. 1992; Hammond and Hammond 2001; Licato et al. 2001; Gao et al. 1997; Nakamura et al. 2002) . The vessels contain a silicon membrane that allows passive diffusion of oxygen and carbon dioxide enhancing successful growth of cells (Goodwin et al. 1993; Freed and Vunjak-Novakovic 1997; Gao et al. 1997; Doolin et al. 1999; Becker and Blanchard 2007) .
Cell lines. B16.F10 mouse melanoma cells (American Type Culture Collection, Manassas, VA) were primarily grown as a 2D monolayer in McCoy's media 10% fetal bovine serum (FBS) and 0.2% Gentamycin (Mediatech, Cellgro, Manassas, VA; Mid Sci St. Louis, MO) HaCaT human keratinocytes were a generous gift from Dr. Mark Jaroszeski (University of South Florida, Tampa, FL). These cells were grown in flasks without feeder cells because they had the ability to adhere tightly to the flask and to themselves (Coolen et al. 2007 ). The HaCaT cells were grown in Dulbecco's modified essential medium (DMEM), 10% FBS, and 0.2% Gentamycin. All cells were grown in a humidified incubator at 37°C and 5% CO 2 . Cells were removed from flasks using trypsin without ethylenediamine tetraacetic acid. Following removal from the flasks, trypsinized cells were neutralized with media, washed in Dulbecco's phosphate-buffered saline and kept on ice until they were ready to be utilized for the 3D model. 3D tissue culture. HaCaT cells were prepped for the HARVs (mentioned above) the total number of viable cells were determined using trypan blue and counted using a hemocytometer. Cells were resuspended in the final volume needed to fill the vessel of choice. HaCaT cells (40-60×10 6 ) injected into a HARV produced a spheroid with a 1-cm diameter. To load the HARV, both luer locks were turned to the open position, a syringe attached to a 14-gauge cannula aspirated the HaCaT cells resuspended in media from a conical, then this syringe was fastened to one open luer lock port, and then the cells were slowly injected into the HARV. All bubbles were removed from the vessel by injecting most of the cells into one port of the HARV and then slightly tilting the vessel at an angle to drive all the bubbles into another syringe attached to the opposite port. In a piston-like motion, bubbles were gently forced out of the HARV avoiding increased pressure on the membrane. The removal of all bubbles reduced the disruption to spheroid formation (Gao et al. 1997) .
HARV equipment setup and utilization. During the initial setup of equipment, the bioreactor motor systems RCCS-1 or RCCS-4SCQ (Synthecon) were disinfected with 70% ethanol and sporicide. Once the HARVs were placed in the incubator, the vessels were attached to the base of the bioreactors by fastening the HARV into place using a clockwise rotation. To begin aggregate formation, the cells were initially rotated at 15 to 17 rotations per minute depending on the amount of cells in the HARV. The cells remained suspended in media rotating with minimal interference. The pH and oxygen levels remained homeostatic because the passive diffusion of oxygen and carbon dioxide between the cells, media and incubator allowed even exchange of gases. This procedure of oxygenation ensured that viable cells received the necessary nutrients to continue replication. Once HaCaT cells formed the desired spheroid size, the vessel was removed from the base, and the spheroid was manipulated towards the vessel's sample port for injection of tumor cells.
Injection of B16.F10 into spheroids. B16.F10 cells were harvested, washed, resuspended in McCoy's media, and counted using a hemocytometer. The cells were then concentrated to the desired volume containing 2-10×10 6 B16.F10 cells. A 28-1/2 gauge needle was used to inject B16.F10 into the HaCaT spheroids. The spheroid was maneuvered toward the sampling port, the cap removed, and then the spheroid was delicately injected with 25-50 μl of B16.F10 cells. The elastic spheroid expanded as the cells were injected; a slight ballooning of the spheroid was observed during the injection. The spheroid was durable enough to withstand one to three different injection sites, but one injection was sufficient. The sample port was sealed again, and additional medium was added to the HARV to remove excess bubbles. A mixture of two different media were used to promote the growth of B16. F10/Keratinocyte; this included 70% McCoy's and 30% DMEM. The media mix was used in media changes that ranged from 20% to 50% of the total HARV volume. To avoid two media changes in 1 d, the Co 2 levels were decreased to 1.5-1.9%. The reusable HARVS were cleaned after each use, per manufacturer's instructions (Synthecon) . Briefly, the HARVs were soaked in sterile deionized or nanopure water overnight. Then, the HARVs were soaked in 70% ethanol for 8-16 h, air dried, wrapped in foil, and autoclaved at 105-110°C for 30 min.
Double staining immunohistochemistry.
Immunohistochemistry (IHC) was used to identify different cell types within the spheroid. Spheroids containing proliferating B16.F10 cells were fixed in 4% paraformaldehyde or 10% formalin for at least 6 to 12 h up to 24 h, processed, and embedded in paraffin wax. In order to perform a double immunostaining, the samples were depariffinized using xylene to break down paraffin. Then, samples were dehydrated and rehydrated using different concentrations of ethanol. The following procedures were performed at room temperature. The recipe for deparaffinization was as follows: sections were dipped in Coplin jars containing three xylene washes, two 100% ethanol washes, one 95%, and one 80% ethanol wash. All steps described from here were performed in a humidified chamber. The samples were enzymatically pretreated for antigen retrieval using 0.4% pepsin in 0.01 M HCL. After the incubation period, samples were rinsed with 1× phosphate-buffered saline (PBS, Sigma, St. Louis, MO). Since two different secondary antibodies were used in this assay, an endogenous peroxide quenching step was necessary to avoid nonspecific binding of secondary conjugated Strepavidin-horseradish peroxidase (HRP) which reacts with diaminobenzidine (DAB). The samples were blocked with 10% hydrogen peroxide in methanol and also blocked with serum corresponding to the species source of their secondary antibodies. For mouse antihuman AE1/AE3 (MAB3412, Millipore, Billerica, MA) the secondary antibody source was goat so all samples were blocked with 2.5% normal goat serum diluted (Thermo Scientific, Waltham, MA) in 1× Tris-buffered saline (TBS, Boston Bioproducts, Worcester, MA) containing 0.1% bovine serum albumin (BSA). TBS was used instead of PBS to avoid any interference with the secondary antibody goat anti-mouse IgG bound to alkaline phosphatase AP (80200 QED Bioscience, San Diego, CA). For rabbit antimouse S100 (AB941, Millipore) the secondary antibody source was bovine, and this serum was used to block for the bovine anti-rabbit IgG-HRP (sc-2370, Santa Cruz Biotech, Santa Cruz CA). In this experiment, AE1/AE3 (1-10 mg/ ml) was diluted first to 1:100 in TBS + 0.1%BSA. The secondary antibody goat anti-mouse IgG AP was diluted 1:20 in TBS + 0.1%BSA. The samples were developed with the East Red substrate chromogen developer solution. The East Red solution was used per manufacturer's instructions (Thermo Scientific). Briefly, 3 mL of napthol phosphate substrate was mixed with one drop 40 μl of Liquid Fast Red Chromogen. Then, all staining procedures were repeated with the S100 primary antibody. The samples were blocked with 2.5% normal bovine serum and then incubated with S100 diluted to 1:800 in 2.5% normal bovine serum. Then, the samples were incubated with secondary antibody bovine anti-rabbit IgG-HRP diluted 1:20 in 2.5% normal bovine serum. A DAB substrate was used per manufacturer's instructions. One 10 mg tablet was mixed in distilled water (Acros EASYtablets, Geel, Belgium) to develop the stain. The sample slides were counterstained using hematoxylin (Sigma), rinsed, mounted with an aqueous mounting media (Polysciences, Warrington, PA), covered with a 20×60 mm cover slip (Corning, Corning, NY), and slides were observed under a light microscope. Negative controls were included to show specificity of the primary antibodies to their secondary antibodies. The primary antibody was added to the slide, but the respective secondary antibody that did not match was also added showing no reactivity.
Proliferation assay and extracellular matrix staining. A double IHC was performed to stain for proliferating cells and cells synthesizing their own extracellular matrix. An Abcam (http://www.abcam.com/ps/pdf/protocols/ihc_p.pdf) protocol was used to perform staining procedures. Briefly, slides were deparaffinized and rehydrated, antigens were unmasked using 20 μg/mL of Proteinase K 30 min 37°C, and samples were blocked using goat serum plus 0.025% triton X. The slides were first labeled with an anti-Ki67 antibody at a 1:200 dilution (ab15580 Abcam, Cambridge, MA) or an anti-Fibronectin antibody at a 1:200 (ab2413, Abcam) and then incubated with goat anti-rabbit IgG-HRP as the secondary antibody at a 1:20 (ab6721, Abcam). The labeled samples were developed using DAB and then visualized under a light microscope. The slides were counterstained using AE1/AE3 1:200 and secondary antibody goat anti-mouse IgG AP 1:200 as mentioned above. A negative control was tested along with the sample slides, where the secondary antibody was tested for nonspecific binding in the absence of the primary antibody.
TdT assay and IHC. The TdT-FragEL DNA Fragmentation Detection assay (Calbiochem, San Diego, CA) was performed on paraffin-embedded samples to identify cells undergoing cell death followed by a double IHC assay to designate the cell types that were experiencing apoptosis. A methyl green counterstain distinguished normal cells from apoptotic cells by producing a tan or blue-green stain for viable cells and a dark brown stain for dead cells. A positive and negative control was performed simultaneously with the assay. The positive control included DNAse I (Promega, Madison, WI) to intentionally nick the DNA ends, and in the negative control the TdT reaction mix was not added to the sections. The assay was performed per manufacturer's instructions. Briefly, the samples on the slide were deparaffinized and rehydrated by immersing slides in xylene, 100% ethanol, 90% ethanol, 80% ethanol, 70% ethanol, and rinsed in 1× TBS. The sections were permeabilization using 2 mg/mL of Proteinase K diluted to 1:100 in 10 mM Tris pH 8, then blocked for endogenous peroxidases with 30% hydrogen peroxide diluted 1:10 in methanol. The sections were equilibrated with 5× TdT equilibration buffer diluted 1:5 in deionized water. TdT labeling reaction mix was prepared by mixing TdT Labeling Reaction and TdT enzyme. The labeling reaction was terminated with stop solution and then blocked with provided blocking buffer. The Strep-HRP conjugate was diluted 1:50 in blocking buffer and then developed using a DAB solution.
Before counterstaining, a double IHC was performed similar to the one described above. Briefly, endogenous peroxides were reblocked with 10% hydrogen peroxide diluted in methanol, and then samples were blocked with 2.5% normal goat serum. The primary mouse anti-human AE1/AE3 antibody was added to the sections diluted 1:200 in 2.5% normal goat serum (all chicken, goat, and rabbit serum Molecular Probes, Carlsbad, CA), and the secondary goat anti-mouse IgG AP was diluted 1:50 in 2.5% goat serum. Then, all slides were developed using Fast Red. Next, sections were blocked with 2.5% rabbit serum and incubated with primary antibody S100 goat anti-mouse (sc-7849, Santa Cruz Biotech) diluted 1:100 in rabbit serum. The sections were incubated with the secondary rabbit anti-goat IgG-HRP (HAF017 R&D Systems, Minneapolis, MN) diluted 1:20 in rabbit serum and developed using DAB. Finally, the sections were counterstained with methyl green, mounted using permount (Fisher, Pittsburgh, PA) and then observed under a light microscope. Viable cells were counted using a micrometer found in the ocular lens of the scope. Double immunofluorescence. This assay was performed based on an immunofluorescence (IF) protocol described by the Cell Signal website (www.cellsignal.com/support/ protocols/IF.html). Briefly, the sections were deparaffinized and rehydrated using xylene, 100% ethanol, and 95% ethanol and rinsed in deionized water. The antigen retrieval step involved using 10 mM of sodium citrate pH 6 in deionized water. The slides were placed in a glass container separate from one another and heated in a water bath up to 87°C for 20 min. The sections were blocked using cocktail blocking buffer made up separately for the two different host serums. The total volume used was 25 mL; 2.5 mL 10× PBS, 1.25 mL normal chicken or rabbit serum, 21.25 mL of deionized water were mixed, and 75 μl of TritonX-100 (100%, Sigma). A primary antibody cocktail was prepared separately and then combined on the slide; a 10 mL antibody dilution buffer was prepared using 400 μl of 10× PBS, 3.6 mL of deionized water mixed, 0.040 g of bovine serum albumin (BSA, Fisher) and 12 μl TritonX-100. Mouse anti-human AE1/AE3 was diluted 1:100, and goat anti-mouse S100 (sc7849, Santa Cruz Biotech) was diluted 1:50 in dilution buffer. The cocktail of antibodies were incubated at 4°C overnight. The following day, the slides were washed in 1× PBS three times; between washes 2 and 3, an additional wash was added, 0.4 M high-salt 1× PBS solution to reduce background staining. The sections were blocked a second time to ensure there would be no nonspecific binding by the secondary antibodies. The rabbit anti-goat IgG flourescein isothiocyanate (FITC) was diluted 1:100, and chicken anti-mouse IgG Rhodamine was diluted 1:100 (sc-2777 and sc-2861, Santa Cruz Biotech). The sections were washed with PBS and high-salt PBS. The sections were also re-incubated with rabbit anti-goat IgG FITC diluted to 1:50 to ensure binding of this secondary antibody. The samples were mounted using Vectashield medium (Vectashield, Burlingame, CA) and excited at two different wave lengths Fluorescein Iso-thiocyanate 490/ 520 nm and Tetramethylrhodamine Iso-thiocyanate 557/ 576 nm for detection. A negative control was performed simultaneously with this assay. The primary antibodies were added, but mismatched secondary antibodies were used to check for cross reactivity.
Results
Growing cells without the scaffolding. B16.F10 cells injected into the HARV without a scaffold aggregated towards each other but were loosely connected or simply floated in the vicinity of one another (data not shown). This was due to the HARV's horizontal rotation exerting forces onto the denser particles colocalizing the cells in the same quadrant of the vessel (Gao et al. 1997; Hammond and Hammond 2001) . These aggregates were easily disturbed when the vessel was removed from the base and during media changes. These observations suggested that a scaffold would be needed.
Establishing the scaffolding. The HaCaT cells also migrated towards each other when cultured in the HARV; however, due to their tightly adhesive properties, they formed a stable spheroid scaffold. Injecting 40-60×10 6 cells into the HARV resulted in the formation of a 1 cm diameter spheroid aggregate after 24 to 48 h (Fig. 1A) . These spheroids were stable and could be transferred from the HARV to a petri dish without disruption. The cells were also malleable and able to resist needle punctures as well as absorb the forces applied when injecting fluid into them. The maximum volume that could be injected into the spheroid before rupturing ranged between 50 and 200 μl depending on the aggregate's size and thickness (Fig. 1B) .
Melanoma spheroid. It was determined that B16.F10 cells could be injected into HaCaT cell spheroids after 48 to 72 h post spheroid formation. B16.F10 cells injected into the center of the HaCaT scaffold underwent proliferation for 5-7 d after inoculation. Figure 1C demonstrates that the cells were proliferating and had begun to differentiate into pigment-producing mature cells.
Assessing cellular viability. An immunohistochemistry assay was performed to confirm that the cells within the tumor spheroid were viable (Fig. 2) . It was observed that 80% of the cells remained viable in this environment up to 4-6 d while residing in culture. Histological evaluation verified that the nucleus was intact, the cytoplasm was free of granules, and that more HaCaT cells were found in culture compared to B16.F10 with a 3:1 ratio. Although ten times the amount of HaCaT cells was used to construct the scaffold; the rapidly proliferating B16.F10 cells made up one third of the construct.
Evidence of cellular viability. The TdT and double immunohistochemistry assays were preformed to provide additional evidence of cellular viability. It was observed that 80-90% of the B16.F10 cells remained viable after being in the HARV up to 7 d. The positive control slide was subjected to DNAseI (Fig. 3A) , which nicked the DNA and allowed for labeling by TdT to produce a dark brown stain indicating cells had undergone apoptosis. The negative control showed that the nuclei of cells did not stain (data not shown). In addition, IHC was performed to show the specific cells such as HaCaT and B16.F10 were either reactive or nonreactive to the TdT assay (Fig. 3B) . The sample slides showed that >80% of B16.F10 and HaCaT nuclei had a blue-green or tan staining. We observed that B16.F10 looked as though they were proliferating and grouping together forming isolated populations.
B16.F10 proliferation and extracellular matrix synthesis. An IHC assay was performed on spheroids to stain for proliferating B16.F10 cells using Ki67 antibody. The nuclei of the cells were observed to be stained different shades of brown which indicated differences in proliferation. The nuclear staining procedure can be used to determine if cells are in various stages of the cell cycle based on the intensity of the stain (see arrows in Fig. 4B) . A negative control demonstrated that non-specific binding of Ki67 is not observed (Fig. 4A) . The spheroids were also stained to identify whether B16.F10 cells proliferating in the spheroids have the ability to produce their own extracellular matrix. Spheroid was sectioned and stained with Fibronectin antibody. Fibronectin, a component of the extracellular matrix, was observed at the surface of cells as depicted in Fig. 5 . Fibronectin staining displays a matrix-like component that surrounds the cells. A negative control slide showed that fibronectin only binds specifically to surface antigens present (data not shown). The AE1/AE3 antibody binds to keratinocyte surface marker and allowed for localization of specific cell types within the spheroid (Fig. 5) . Dual staining indicates that extracellular matrix is being produced by both cell types since AE1/AE3 negative cells were found to be fibronectin positive.
Localization and orientation of B16.F10 and HaCaT. A double immunofluorescence assay was performed to evaluate spatial orientation of HaCaT cells relative to B16.F10 tumorgenic cells (Fig. 6 ). This particular spheroid was harvested 5 d after incubating in the HARV. Figure 6A shows the fluorescent excitation of B16.F10 cells by FITC wavelengths, and Fig. 6B shows excitation of HaCaT cells by tetramethylrhodamine isothiocyanate (TRITC) wavelengths independent of one another. The images were merged to show the amount of overlap that occurred between cells when growing in the scaffold (Fig. 6C) . The green fluorescent label shows grouping of B16.F10 surrounded by or integrated within HaCaT cells in red (single arrows). The B16.F10 cells appeared as though they were grouped in isolated populations as well as growing on top of the HaCaT cells (single arrows). The HaCaT cells appeared as though they were organized; flattening and stacking making up the walls of the spheroid with B16.F10 growing on top of the HaCaT (triple arrows). These cellular arrangements and growth patterns were clearly identified in the separate fluorescent signal images compared to the merged image where the strong fluorescent signal seemed to be quenched (Fig. 6A, B) , while the B16.F10 appeared as though they were growing processes and beginning to display elongated morphological changes (arrows in Fig. 6D-F) .
Discussion
While several scaffolds were evaluated for their ability to construct a 3D tissue model, HaCaT spheroids provided a useful framework that could support the development and proliferation of B16.F10 cells. HaCaT cells grown in the HARV were able to stick together forming a malleable, stable construct that could mimic the complex environment needed to support the growth and differentiation of melanoma. The horizontal rotation, laminar fluid flow, hydrodynamic forces, and oxygenation provided by the HARV (Hammond and Hammond 2001) allowed for this 3D modeling to be possible (Fig. 1) . Evidence that strengthens our hypothesis includes the IHC, TdT, and IF assays. These results demonstrated that B16.F10 cells were able to proliferate and differentiate normally; producing mature pigmented cells as seen in malignant cancer development (Tai et al. 1983) . HaCaT cells formed spheroids in less time than expected, about 1 to 2 d, with a size of about 1 cm in diameter. The scaffold was able to keep the loose, fluid B16.F10 cells close in proximity to promote tumorogenesis as observed with IF and IHC (Figs. 1, 2, 3, and 4) .
The key to developing the 3D growth of tumor cells was the use of the HaCaT scaffold. The tight adhesive properties of HaCaT cells did not allow much diffusion of nutrients into the center of the construct, but when B16.F10 were injected into the scaffold surrounded by media, it caused an influx of media providing the inner cells nutrients to survive (Fig. 1B) . In future studies, it is possible that the use of growth factors along with fibroblasts could expedite the expansion and development of B16.F10 in less time (Griffith and Swartz 2006) .
In the IHC analysis, we observed a 3:1 ratio of HaCaT to B16.F10, so it is inferred that keratinocytes adhesive proteins were regulating melanoma cells proliferation and survival (Fig. 2) . Evidence of proliferation was provided in the IHC assay (Fig. 4B) . Staining of B16.F10 and HaCaT nuclei indicated the cells were in different stages of the cell cycle. Stable cellular growth, communication, signaling, and survival were observed in HaCaT and B16.F10 cells. These cells were also observed to have the ability to produce their own extracellular matrix while residing in the 3D spheroid construct (Fig. 5) . The IF showed that there was some cell-cell communication between B16.F10/B16. F10 and B16.F10/HaCaT. We observed groupings of B16. F10 in smaller populations while residing in the spheroid and we also observed B16.F10 cells growing on top, adjacent, and integrated with the HaCaT cells. The IF demonstrated HaCaT/B16.F10 cells stacked upon one another forming a pseudo wall or barrier (Fig. 6A-C) . We think the HaCaT cells could be expanding at a slow rate, remain in an undifferentiated state, or possibly driven to a state of differentiation to allow continuous survival of B16.F10 cells. The evidence that supports these observations was revealed through the specific antibodies AE1/ AE3 used in IF. The AE1/AE3 are broad-spectrum pan cytokeratins that measure all states of epithelial cell development. A strong fluorescent signal was observed indicating that HaCaT may be undergoing proliferation and/ or differentiation (Fig. 6A-C) . Further studies need to be conducted to provide additional evidence for the identification of epithelial growth stage while residing in the HARV in the absence of a basement membrane and stroma. The S100 surface marker provided the information that malignant melanoma was present, but further evidence of melanoma developmental is also needed to confirm the predictions of this study. We also observed changes in B16. F10 morphology; the cells were undergoing elongation and forming dendrite-like processes. These results support that B16.F10 were interacting and communicating with adjacent B16.F10 and HaCaT cells while residing in this 3D model (Fig. 6D-F) .
Conclusions
This is the first known report describing the development of a 3D model that produces a free-floating tumor spheroid that can be grown to a size of at least 1 cm. Previously, there was a report of a study that described producing an organotypic coculture system that produced a 3D model ranging 1-2 cm over a 2-wk period. This other model was not free floating and was evaluated for potential skin transplantation not for tumorigenesis (Schoop et al. 1999 ). The study we report here demonstrated that keratinocytes were able to provide a template for melanoma proliferation in a 3D in vitro model. In this semisynthetic environment, keratinocytes were a wellorganized cellular construct (Jong et al. 2004 ) that promoted tumor replication and development of B16.F10 cells after injection into the scaffold. The time period it took for the scaffold to organize its cells and support tumor mass formation exceeded the dimensions and time it took cancer cells to develop in the bead, sponge, and matrix scaffolding (data not shown; Goodwin et al. 1997; Becker and Blanchard 2007) . We observed that tumors did not need the extracellular matrix "stiffness" or basement membrane to proliferate or survive in this environment ( Griffith and Swartz 2006) . However, results of this study provided evidence that B16.F10 cells can promote synthesis of extracellular matrix. This suggests that the cells were functional and that there was signaling between B16.F10 and HaCaT. Natural occurring HaCaT cells react similarly in the 3D model regulating B16.F10 growth and survival through cell-cell interaction, promoting the production of extracellular matrix, displaying organized growth patterns, and formation of dendrite-like processes (Li and Herlyn 2000; Hsu et al. 2002; Hindie et al. 2006) . HaCaT and B16.F10 cells remained viable in the center of the scaffold because they received even exchange of nutrients and oxygen while rotating in this system uninterrupted. The heavily pigmented cells located in the center of the scaffold did not appear necrotic over a 10-15 d period (data not shown). Additionally, the physical rotation of cells in the HARV promoted aggregation formation facilitating "normal" cellular behavior in a well controlled, reproducible environment (Hammond and Hammond 2001; Becker and Blanchard 2007; Fischbach et al. 2007 ). There are many factors that can be regulated to ensure that cells behave in a desirable manner including salt, pH, protein concentrations, ligand/ receptor concentration, temperature, adhesive properties, and oxygen solubility (Griffith and Swartz 2006) . Cellular behavior that reacts to specifically enhanced stimulus can be measured by obtaining multiple samples from the 3D culture without jeopardizing the integrity of the experiment. This system is beneficial because it decreases live animal experiments, increases ability to evaluate different aspects of 3D cellular environment, increases sampling size between assays, can isolate particular cells systems, and control experimental conditions for desired experimental analysis.
We are currently using this model to establish treatment regimens that can be translated into in vivo cancer treatments. This model can be used for other applications such as understanding tumorgenic properties, how tumor cells react in the absence of an immune response, and how cells react in the presence of other stimuli that promote or inhibit tumor development. The information gathered from an immune-absent environment can be used and compared to similar reactions that occur in NUDE or SCID mouse models (Fischbach et al. 2007). This model can help investigators study proteins that are present during tumorogenesis such as FGF, VEGF, and interleukin 8, signifying that tumor cells can promote their own angiogenic properties. Additionally, at the DNA level, investigators may be interested in specific gene expression, mutations, and cell signaling such as autocrine loop activity that regulates tumorgenesis. This 3D model could also help uncover the differences in cellular properties between a 3D and 2D model, in the hopes of discovering new information about cells grown in vitro (Hammond and Hammond 2001; Licato et al. 2001; Griffith and Swartz 2006; Becker and Blanchard 2007; Fischbach et al. 2007; Ghosh and Maity 2007; Yamada and Cukierman 2007) . Future studies utilizing this 3D model can include identifying clinical therapies for wound healing, plastic surgery, organ transplantation, species specific diseases, and toxicity of drugs (Licato et al. 2001; Griffith and Swartz 2006) .
